Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18613,894,1.06 [0.91-1.24],0.4611182040916188
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17875,286,1.19 [0.92-1.56],0.1904087675284074
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21092,174,0.92 [0.64-1.32],0.6469069668184578
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13084,1066,1.10 [0.95-1.27],0.2086890496401134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21047,129,0.82 [0.53-1.26],0.3615768254729936
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18657,94,1.16 [0.73-1.83],0.5360988277211982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22475,128,0.83 [0.54-1.27],0.3981396640172396
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22458,84,0.65 [0.38-1.13],0.1255410654530582
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18178,72,1.74 [1.16-2.62],0.0077277489923964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21346,131,1.10 [0.74-1.63],0.6291928756611918
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21301,86,1.14 [0.71-1.84],0.5781551898791899
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22577,70,1.23 [0.74-2.06],0.4234818105492712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22609,64,1.35 [0.80-2.29],0.2612833058032126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22606,61,1.29 [0.75-2.24],0.360508583329047
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,22125,59,1.00 [0.55-1.82],0.9970412534331172
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21023,429,1.13 [0.91-1.40],0.2774894375016565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,20729,135,1.16 [0.80-1.70],0.4341507928992967
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,20906,312,1.15 [0.90-1.48],0.2692557301625961
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16262,96,1.27 [0.82-1.96],0.2794678516315751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16228,62,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16553,387,1.09 [0.86-1.38],0.4719427684962758
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16564,398,1.08 [0.86-1.36],0.5066372268942173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9286,373,1.34 [1.08-1.66],0.0078140452103894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7455,202,1.17 [0.85-1.61],0.3377592665292824
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16223,57,1.14 [0.64-2.05],0.6563791686533588
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19318,756,1.08 [0.91-1.27],0.3698857728118629
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21110,450,0.97 [0.78-1.20],0.7656747694906374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22093,148,1.01 [0.70-1.48],0.9430001792968852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22660,143,0.99 [0.67-1.45],0.9577761467091814
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,22343,83,0.99 [0.60-1.65],0.9783883736839196
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22666,97,1.00 [0.63-1.61],0.9856808054884764
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Stomach,22721,71,1.05 [0.61-1.82],0.8540835858048841
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,22484,291,0.83 [0.63-1.10],0.1968089190959073
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22701,100,0.82 [0.51-1.32],0.4124273201335009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22705,83,0.50 [0.29-0.88],0.0163935735153273
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22621,57,0.54 [0.28-1.07],0.0783490937278515
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",22624,56,0.58 [0.30-1.15],0.1177139862592464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,22566,144,0.62 [0.41-0.94],0.026083205931761
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,22698,62,0.53 [0.28-1.01],0.0534623214431629
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,22584,171,0.93 [0.65-1.33],0.681482286155703
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of breast,11839,43,1.63 [0.95-2.78],0.0746215989091308
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,11698,303,0.81 [0.61-1.08],0.1458295326146763
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21167,187,0.95 [0.68-1.34],0.7809595831965738
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20655,349,0.97 [0.75-1.24],0.8056138586049565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20655,349,0.97 [0.75-1.24],0.8056138586049565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18135,555,1.24 [1.03-1.49],0.0261083967364322
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22111,56,0.99 [0.53-1.86],0.9721708045388092
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22380,58,1.88 [1.22-2.92],0.0045560681513826
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16445,1633,1.01 [0.90-1.14],0.8595873319451561
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21018,635,0.94 [0.78-1.13],0.5212656395626358
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,19964,156,1.20 [0.84-1.71],0.3069611326206493
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21132,167,0.94 [0.65-1.36],0.7492992840377326
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19950,142,1.16 [0.80-1.69],0.4355741441855025
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20570,762,1.18 [1.00-1.40],0.0493200732942281
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20544,736,1.19 [1.00-1.41],0.0453812502523174
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20862,185,1.17 [0.81-1.69],0.4053549248281921
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20861,184,1.17 [0.81-1.69],0.4037336476761979
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16264,1452,1.02 [0.90-1.16],0.7714032896950775
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15001,189,0.98 [0.70-1.37],0.9108397991244476
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16156,1344,1.02 [0.90-1.16],0.7336456249397918
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14868,56,1.39 [0.82-2.33],0.219766956257754
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14902,90,1.13 [0.72-1.80],0.5905166760510948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,18577,529,0.92 [0.75-1.14],0.4506817104400884
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18206,158,0.99 [0.68-1.45],0.9576713334044112
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22356,113,0.94 [0.60-1.48],0.78320208234128
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22415,84,1.00 [0.60-1.67],0.9910747351029364
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21185,34,1.09 [0.51-2.32],0.8321201914482881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",22643,34,1.05 [0.48-2.26],0.9095726769460294
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18082,34,1.04 [0.48-2.22],0.9294098602794252
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Alcohol dependence,21195,44,0.75 [0.35-1.58],0.4440542866128867
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,21119,48,1.38 [0.76-2.50],0.2841221230597823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18083,35,0.61 [0.26-1.43],0.2565377248519321
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18306,258,0.78 [0.58-1.07],0.1196356306202832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression,21283,229,0.75 [0.54-1.04],0.0812461152462602
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression or dysthymia,17958,196,0.78 [0.55-1.10],0.1565535686592533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18155,107,1.15 [0.75-1.76],0.5355121822794963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Other anxiety disorders,21330,63,1.15 [0.66-2.01],0.6165147197096635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,18444,1475,0.95 [0.83-1.08],0.4031657456663312
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16123,100,0.91 [0.56-1.48],0.7091407456312188
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22627,76,0.78 [0.44-1.37],0.3854500953320219
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21420,465,1.06 [0.86-1.31],0.5695103130483095
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,21091,136,0.65 [0.42-0.99],0.0465905987600223
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,21013,58,1.03 [0.56-1.89],0.9166005960524268
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22497,52,1.16 [0.63-2.15],0.6299092413205675
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21570,116,1.11 [0.73-1.69],0.6178613822642748
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,21110,155,1.54 [1.12-2.10],0.0074719482976992
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,22196,116,1.50 [1.04-2.17],0.0294996850712557
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21543,707,0.89 [0.74-1.07],0.2031710002640334
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",20938,102,0.73 [0.45-1.19],0.2018498289798872
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21271,435,0.94 [0.75-1.17],0.5627420581139245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22341,76,0.73 [0.41-1.29],0.2834931118711594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,22323,58,0.65 [0.34-1.27],0.2085570218125718
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,22172,115,0.99 [0.64-1.52],0.9483949667863374
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",21878,415,0.86 [0.68-1.08],0.1951645245943631
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21715,252,0.85 [0.63-1.15],0.297166010277424
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21523,60,0.71 [0.38-1.34],0.2878097071197736
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21597,134,0.90 [0.60-1.35],0.6048357750067654
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21568,105,0.80 [0.50-1.29],0.3570635711055659
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17378,250,0.93 [0.69-1.26],0.6485214998741538
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17726,598,1.06 [0.87-1.28],0.5780268251646649
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21344,298,0.97 [0.74-1.27],0.805532515499801
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22305,80,1.19 [0.72-1.97],0.5029206502178016
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2562,80,1.04 [0.61-1.79],0.884072174075967
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",19823,80,1.21 [0.74-2.00],0.4501304087741092
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,21753,141,1.37 [0.97-1.94],0.0767960006278397
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,21688,76,1.45 [0.91-2.30],0.1199289930791465
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",21818,77,1.21 [0.74-1.99],0.4430810405992489
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22061,98,0.98 [0.62-1.56],0.9284699867080344
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,22626,138,0.98 [0.66-1.46],0.9261142571618516
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,21518,112,1.01 [0.65-1.55],0.9816258599989512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14004,4505,1.12 [1.02-1.22],0.0138290935464573
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,21791,93,1.72 [1.19-2.49],0.004181653428642
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14836,3159,1.08 [0.98-1.19],0.1265473881314705
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,14880,3203,1.08 [0.98-1.19],0.1130358394074138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11784,107,1.58 [1.08-2.31],0.018590637727059
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19883,1794,1.17 [1.05-1.31],0.0046012666051518
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,19159,1070,1.11 [0.96-1.28],0.157801456838329
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21358,338,1.09 [0.85-1.39],0.4977284939258735
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21706,686,1.21 [1.02-1.44],0.0249151772638394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22563,129,1.28 [0.87-1.86],0.2081117402027498
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18520,431,1.27 [1.03-1.56],0.0253584650326655
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19519,1455,1.22 [1.08-1.37],0.0015126078708148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21592,139,1.24 [0.86-1.80],0.2439601831763016
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,21812,281,0.96 [0.72-1.26],0.7474109106813482
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21566,113,1.60 [1.12-2.29],0.0102287435236952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21567,114,1.63 [1.14-2.32],0.0069132995214356
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11786,109,1.56 [1.07-2.27],0.0194192608236143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16695,69,2.18 [1.53-3.12],1.813660476548009e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,16796,170,1.33 [0.97-1.84],0.0777267057846883
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8863,140,1.17 [0.81-1.71],0.4057049072368074
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9398,675,1.26 [1.05-1.51],0.0139682738610288
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,16720,94,1.31 [0.85-2.01],0.2199385402675698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16747,121,1.27 [0.86-1.87],0.2269690869813144
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21112,288,1.40 [1.10-1.79],0.0067660700283487
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",21476,198,0.93 [0.67-1.31],0.6959695430417359
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",21507,178,1.05 [0.74-1.48],0.797220186609075
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",21612,158,1.07 [0.74-1.55],0.7114047320806897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21103,103,1.01 [0.64-1.59],0.9590222750893416
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21173,173,1.01 [0.71-1.44],0.9608110061520552
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21032,164,0.76 [0.52-1.11],0.1513638673635647
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21010,142,0.75 [0.50-1.13],0.168030977354372
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22447,136,0.77 [0.50-1.17],0.2157711916536168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,21372,504,0.91 [0.73-1.12],0.3667900598271958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,21070,118,0.58 [0.37-0.93],0.0248710830964123
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,16748,2123,1.08 [0.97-1.20],0.168139414208462
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22563,75,0.83 [0.48-1.43],0.4944520660261609
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20207,253,1.25 [0.95-1.63],0.1050198264908139
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20179,225,1.27 [0.96-1.69],0.0932287695587311
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,21467,287,1.26 [0.98-1.63],0.0701530999013673
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,21458,278,1.31 [1.01-1.68],0.0397585388618165
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22010,544,0.96 [0.78-1.17],0.6852061194296508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,21558,92,0.74 [0.44-1.23],0.2395382177676028
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,21604,138,1.21 [0.83-1.75],0.3215139146448384
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21814,348,0.84 [0.65-1.08],0.179054566366113
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,21602,136,0.65 [0.42-1.00],0.0507532160305935
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7191,75,1.05 [0.62-1.77],0.8534805971731618
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19682,1118,1.04 [0.90-1.19],0.6122254499760551
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,21087,239,1.18 [0.89-1.56],0.2596647871394115
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21140,292,1.12 [0.86-1.46],0.3870062278288304
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21140,292,1.12 [0.86-1.46],0.3870062278288304
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21072,851,1.03 [0.88-1.21],0.712447838422614
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Asthma,14758,851,1.07 [0.91-1.26],0.420551808191225
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14379,851,1.08 [0.92-1.27],0.3732215520800566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14748,841,1.05 [0.89-1.23],0.5797663519467897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22170,127,1.85 [1.35-2.52],0.0001128390477329
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,21125,98,1.96 [1.41-2.73],6.779039797974452e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22263,98,1.97 [1.41-2.74],6.225404935425377e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21118,91,1.85 [1.29-2.64],0.0008233939430074
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,19953,144,1.00 [0.68-1.46],0.9982369916473456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,20100,291,1.15 [0.89-1.49],0.2825469939412364
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21054,130,1.40 [0.99-1.98],0.0585035002722094
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14682,6328,0.95 [0.88-1.03],0.182244748436455
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22286,331,1.01 [0.78-1.30],0.9388363033078424
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22718,38,1.33 [0.67-2.62],0.4191346260835029
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,22720,34,1.48 [0.75-2.92],0.2625978115285293
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,22044,89,1.27 [0.82-1.98],0.2822113362445456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22048,93,0.79 [0.48-1.31],0.3667428936350617
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22715,42,1.16 [0.58-2.31],0.674769393590835
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22051,96,0.57 [0.34-0.95],0.0323981760086775
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21778,90,1.51 [1.01-2.26],0.0423303422644938
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22610,59,1.68 [1.06-2.66],0.028465267991579
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16049,334,1.06 [0.82-1.36],0.6703927675499439
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18245,2530,0.91 [0.82-1.01],0.0642054559571621
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,16115,400,0.83 [0.65-1.05],0.1231732525785179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16527,812,0.90 [0.76-1.07],0.2268480826909038
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15801,86,0.85 [0.51-1.42],0.5300057392996858
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15990,275,0.83 [0.62-1.11],0.1977754804311989
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15796,81,1.18 [0.72-1.92],0.5164059380155102
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,15913,198,0.89 [0.64-1.25],0.5178340903667566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,15857,142,1.57 [1.13-2.18],0.0068684593466832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22545,97,1.66 [1.13-2.42],0.0090328493197533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,15859,144,0.99 [0.68-1.46],0.979403057703322
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16682,967,0.86 [0.74-1.01],0.0639025612430265
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,22590,85,0.55 [0.31-0.95],0.0329563327914369
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,16198,483,0.96 [0.77-1.18],0.6738988449888264
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15934,219,0.91 [0.66-1.25],0.5609716552097961
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22593,121,0.94 [0.62-1.44],0.7859667904509966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,22578,73,0.45 [0.24-0.82],0.0092597608780181
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,19141,2036,0.96 [0.86-1.08],0.5157367719058796
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,17888,783,1.04 [0.88-1.23],0.6358811442402227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,17239,134,1.16 [0.80-1.70],0.4287587606296666
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,17210,105,1.06 [0.68-1.66],0.7820390673021076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18215,1110,0.88 [0.76-1.01],0.0772015014886619
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21671,745,1.00 [0.84-1.19],0.9971531110864787
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,16636,2284,0.98 [0.89-1.09],0.7310524587643101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22374,44,0.83 [0.40-1.73],0.6222851317103928
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",22658,57,0.87 [0.46-1.65],0.6656174837958162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,20983,57,0.87 [0.46-1.65],0.6629225818768756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,20968,42,0.88 [0.42-1.86],0.7418102849950903
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",22578,137,1.24 [0.85-1.79],0.2624038937463259
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,21063,137,1.24 [0.85-1.80],0.2623582451742661
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21053,127,1.31 [0.90-1.91],0.1617369473887476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21543,617,0.96 [0.80-1.16],0.687509490294612
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21534,608,0.96 [0.79-1.16],0.6778993054503357
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14476,124,0.94 [0.62-1.44],0.7842649195604017
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal stricture,22137,124,0.97 [0.63-1.48],0.873893078206907
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14432,80,1.29 [0.81-2.07],0.2831386748850248
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15242,890,1.01 [0.87-1.18],0.877704689976521
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14502,150,0.60 [0.40-0.91],0.0171403507166452
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14672,320,1.09 [0.85-1.40],0.5188818961415019
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,20654,288,1.10 [0.85-1.44],0.4573573252418725
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22252,91,1.21 [0.77-1.91],0.401777410664021
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14458,106,0.87 [0.55-1.37],0.5471842785472409
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14405,53,1.18 [0.66-2.13],0.5749473586470566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15295,943,1.00 [0.86-1.17],0.9904204507442824
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,14709,357,1.08 [0.86-1.37],0.5038339635814066
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22236,75,1.32 [0.82-2.14],0.2559792741960579
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,21844,125,0.90 [0.59-1.38],0.6387781084202625
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,21789,70,1.09 [0.64-1.85],0.7639153182510903
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21245,711,0.93 [0.78-1.11],0.4406047468035921
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,21113,579,0.99 [0.82-1.21],0.949896160925993
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,20650,116,1.04 [0.68-1.60],0.8488310040122
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20589,55,0.87 [0.46-1.66],0.6771324974448822
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,20605,71,1.19 [0.70-2.02],0.5090314258478654
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22535,71,1.20 [0.71-2.02],0.5033463266846627
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21244,338,1.25 [0.99-1.59],0.0611598788695314
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,20981,75,0.91 [0.52-1.58],0.7354678435283556
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,20970,64,0.90 [0.50-1.63],0.7307865133047462
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",20962,56,1.42 [0.83-2.43],0.2070459158146894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21117,211,1.34 [1.00-1.79],0.0495950632536566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,21108,202,1.31 [0.97-1.77],0.0765255484224062
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19079,1575,0.94 [0.83-1.06],0.3173498118412249
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22192,99,1.26 [0.82-1.93],0.2910185893229565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22309,436,0.87 [0.69-1.09],0.229156791410883
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20674,603,0.82 [0.68-1.00],0.0540749656004771
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,21699,381,0.98 [0.77-1.24],0.8647700800109266
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21388,70,1.17 [0.69-1.97],0.5657342283540789
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,21592,274,0.98 [0.74-1.30],0.8730988172490474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22413,93,1.43 [0.94-2.19],0.094516021498679
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22387,67,1.60 [1.00-2.55],0.0486156684056071
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22374,54,1.63 [0.98-2.71],0.0617301172305353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22303,76,1.04 [0.61-1.76],0.8906932450548574
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22301,74,1.05 [0.61-1.78],0.8696845143859154
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21922,49,0.60 [0.29-1.23],0.1626566868194848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22237,364,0.96 [0.75-1.23],0.7647073322609124
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20186,115,0.72 [0.45-1.14],0.1593182054011347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20168,97,0.66 [0.40-1.10],0.1084462233839385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20137,66,0.63 [0.34-1.16],0.1381765709210574
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20289,218,0.92 [0.67-1.27],0.6160170681561209
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20270,199,0.86 [0.61-1.20],0.3799306570571552
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14837,4354,0.90 [0.82-0.98],0.0111173941477482
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16413,2711,0.92 [0.83-1.01],0.0824662707200042
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20148,1283,0.89 [0.77-1.02],0.0859684067311534
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,13884,182,1.14 [0.82-1.58],0.4404630766201363
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14286,584,0.97 [0.80-1.18],0.7694987796471626
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22215,176,1.15 [0.83-1.61],0.3968303328616531
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22220,160,1.13 [0.80-1.60],0.4851139158386656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15309,1607,0.91 [0.81-1.04],0.1627360870492362
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17802,1607,0.92 [0.81-1.04],0.1970980748338134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,13796,94,0.73 [0.44-1.23],0.2367635246410154
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",21957,91,0.81 [0.49-1.35],0.4149539403383314
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13992,290,0.92 [0.70-1.22],0.5586026223463634
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,13822,120,0.79 [0.51-1.23],0.2975664397673762
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14137,435,1.01 [0.81-1.27],0.923640403693879
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22505,217,1.09 [0.80-1.48],0.5934002440131168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14413,711,1.00 [0.83-1.19],0.9675837353027492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14258,556,0.76 [0.61-0.94],0.0116198043468853
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15007,1305,0.91 [0.79-1.04],0.1575810863707526
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13793,91,0.51 [0.30-0.88],0.0147681460830297
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13994,292,0.73 [0.54-0.97],0.031387488488204
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13778,76,0.94 [0.55-1.62],0.8233462113419772
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13789,87,1.14 [0.71-1.84],0.5887303277847009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14132,430,1.00 [0.80-1.25],0.9950833552356652
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14089,387,1.01 [0.80-1.28],0.9180141297697691
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17071,271,0.88 [0.65-1.18],0.3859934150733541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22015,101,0.96 [0.60-1.52],0.8513725877318391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,21983,69,1.18 [0.70-2.00],0.5265347262616131
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18776,75,0.67 [0.37-1.19],0.1728845006033886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19065,364,0.93 [0.73-1.20],0.5794982062454477
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19636,935,0.97 [0.83-1.14],0.7403271858504512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18937,236,0.90 [0.66-1.23],0.5115473410271061
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18812,111,0.96 [0.61-1.49],0.8418140347189862
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19392,691,1.00 [0.83-1.19],0.9646764146782264
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18743,42,0.51 [0.23-1.13],0.0981294940119689
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18915,214,0.87 [0.62-1.21],0.4003534765718639
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18787,86,0.68 [0.39-1.16],0.156119248238646
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18785,84,0.97 [0.58-1.61],0.9028804145811516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18831,130,1.28 [0.89-1.85],0.1782182605712378
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18761,60,1.00 [0.55-1.80],0.9968575672820882
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18985,284,1.09 [0.84-1.43],0.5202987776973695
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19194,329,0.74 [0.57-0.97],0.0311428345900951
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,18946,81,0.77 [0.45-1.32],0.3431871372027815
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,18981,116,0.65 [0.41-1.04],0.0703825355941035
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18951,86,0.89 [0.53-1.48],0.6497544892856264
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",18906,41,1.02 [0.50-2.09],0.9530912551433548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19029,164,1.15 [0.81-1.63],0.4315413807588913
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19018,153,1.26 [0.89-1.79],0.1927031925725731
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19161,296,1.09 [0.84-1.42],0.5337177518134129
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18922,57,0.96 [0.52-1.78],0.9090384436681428
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,18966,101,1.30 [0.86-1.98],0.2163808292888333
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19004,139,1.12 [0.77-1.63],0.5596048097105265
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18915,50,0.55 [0.27-1.12],0.0996653621319551
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19315,450,0.76 [0.60-0.96],0.021837267436513
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19048,183,0.89 [0.62-1.26],0.5028331758936597
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19119,254,0.60 [0.44-0.83],0.0017926985946579
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20355,237,0.76 [0.55-1.04],0.0845779615004565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20550,432,0.76 [0.60-0.96],0.0225530032950484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20158,40,1.21 [0.61-2.41],0.5811443319638332
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20166,48,0.72 [0.35-1.47],0.3663140578351939
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20206,88,0.65 [0.38-1.11],0.112296292832113
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16556,4026,0.98 [0.90-1.07],0.6565117445171351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8775,853,1.08 [0.91-1.27],0.3735625603482774
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19044,290,1.54 [1.21-1.94],0.0003429867446277
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18833,79,1.50 [0.96-2.36],0.0767016821558368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19096,64,2.26 [1.56-3.28],1.502503465874304e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19120,88,1.17 [0.73-1.88],0.5210752874825945
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19111,79,1.81 [1.20-2.72],0.0043046280340915
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22347,248,1.35 [1.04-1.76],0.0233669289405378
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22125,86,1.11 [0.69-1.80],0.6564841330765657
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22282,183,1.37 [1.01-1.85],0.0418964033566508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22176,77,1.24 [0.76-2.01],0.38560028557893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19841,1185,1.04 [0.90-1.19],0.5950909153366246
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,18769,113,0.95 [0.61-1.49],0.822096526186167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18746,90,0.78 [0.46-1.31],0.3450700467813906
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19016,360,1.00 [0.78-1.28],0.9931194581204196
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18796,140,1.23 [0.85-1.78],0.2792250242981153
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19383,727,1.02 [0.86-1.22],0.7881502285685157
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8412,490,1.15 [0.94-1.42],0.1801798000631903
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7990,68,0.91 [0.52-1.61],0.7559231328832877
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,7982,60,1.31 [0.76-2.24],0.33135322517713
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7991,69,1.03 [0.59-1.78],0.9239906482451808
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8013,91,1.12 [0.70-1.80],0.6416842571185678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8032,110,0.97 [0.62-1.52],0.9018656746796856
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11729,226,1.24 [0.93-1.65],0.148580418967068
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11580,77,0.59 [0.32-1.06],0.076473588583408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11581,78,1.60 [1.05-2.43],0.0283736155113441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11559,56,1.82 [1.18-2.81],0.0068873519118569
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11703,162,1.18 [0.84-1.67],0.3429851746807931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11591,50,1.19 [0.64-2.23],0.5776038225540928
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11596,55,0.94 [0.50-1.79],0.8571545486485259
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10841,1778,0.92 [0.81-1.04],0.1617407359552035
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,9126,63,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9113,50,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9536,473,0.90 [0.72-1.13],0.3848836186069797
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9166,103,0.91 [0.56-1.46],0.6855137058475684
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9536,473,0.91 [0.73-1.15],0.4397874755989712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9213,150,0.65 [0.42-0.99],0.0445743861262855
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9279,216,0.57 [0.40-0.82],0.0021096426946474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9079,16,1.10 [0.36-3.34],0.8628661122783087
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9110,47,0.80 [0.39-1.65],0.5462451185621511
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",11852,64,0.87 [0.47-1.59],0.6483085609013358
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,11854,59,0.93 [0.50-1.73],0.8211319769068811
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,11860,30,0.91 [0.38-2.20],0.8294983694133881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",11858,34,0.82 [0.35-1.91],0.6428791719450602
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9133,70,0.61 [0.33-1.13],0.1141720341289753
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9116,53,0.39 [0.19-0.82],0.0129399054213741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9125,62,1.68 [1.07-2.64],0.0245472137692766
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,11859,86,1.43 [0.95-2.17],0.0892064918993894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9255,192,1.16 [0.84-1.60],0.3624602642924391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9153,90,0.89 [0.53-1.50],0.6673896262437236
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",11861,38,1.75 [1.01-3.05],0.0474061930650652
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9169,106,0.64 [0.39-1.06],0.080096828987303
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9112,49,1.07 [0.56-2.05],0.8416690247432006
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9688,625,0.95 [0.78-1.16],0.6293733206880245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22165,81,1.24 [0.77-2.00],0.3777981504720351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19332,657,0.95 [0.79-1.15],0.6122596601795176
